Predictors of insulin sensitivity in Type 2 diabetes mellitus

Diabetic Medicine

Volumn 19, Issue 7, 2002, Pages 535-542

  Bonora, E ^a,b   Targher, G ^a   Alberiche, M ^a   Formentini, G ^a   Calcaterra, F ^a   Lombardi, S ^a   Marini, F ^a   Poli, M ^a   Zenari, L ^a   Raffaelli, A ^a   Perbellini, S ^a   Zenere, M B ^a   Saggiani, F ^a   Bonadonna, R C ^a   Muggeo, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Dyslipidaemia; Glucose metabolism; Hypertension; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY FAT; CALORIMETRY; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC OBESITY; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLYCOGEN METABOLISM; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZATION; STANDARDIZATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS;

EID: 0036421258     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00764.x     Document Type: Article

References (51)

1. DeFronzo RA. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37: 667-687.
2. Reaven GM. The fourth Musketeer-from Alexandre Dumas to Claude Bernard. Diabetologia 1985;38: 3-13.
3. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus. Problems and prospects. Endocr Rev 1998;19: 477-490.
4. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. Obesity and insulin resistance in humans: A dose-response study. Metabolism 1990;39: 452-458.
5. Bonora E, Del Prato S, Bonadonna RC, Gulli G, Solini A, Shank ML et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992;41: 1151-1159.
6. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96: 88-98.
7. McKane WR, Stevens AB, Woods R, Andrews WJ, Henry RW, Bell PM. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism 1990;39: 1240-1245.
8. Karhapaa P, Malkki M, Laakso M. Isolated low HDL cholesterol: An insulin resistance state. Diabetes 1994;43: 411-417.
9. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317: 350-357.
10. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertension 1995;13: 1457-1462.
11. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990;13: 610-630.
12. Yki-Jarvinen H. Toxicity of hyperglycaemia in type 2 diabetes. Diabetes Metab Rev 1998;14: 45-50.
13. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus. J Clin Endocrinol Metab 1999;84: 1544-1550.
14. Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157: 2413-2446.
15. Bray GA. An approach to the classification and evaluation of obesity. In Björntorp P, Brodoff BN eds. Obesity. Philadelphia: JB Lippincott Co, 1992: 294-308.
16. Lohman TG, Rohe AF, Martorell R. Anthropometric Standardization Reference Manual. Campaign IL: Human Kinetics, 1988.
17. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41: 810-817.
18. Segal KR, Gutin B, Presta E, Wang J, Van Itallie TB. Estimation of human body composition by electrical impedance methods: a comparative study. J Appl Physiol 1985;58: 1565-1571.
19. Ferrannini E. The theoretical basis of indirect calorimetry. A review. Metabolism 1988;37: 287-301.
20. Bonadonna RC, Del Prato S, Bonora E, Gulli G, Solini A, DeFronzo RA. Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose. Am J Physiol 1993;265: E943-E953.
21. Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M et al. In vivo glucose metabolism in obese and type 2 diabetic subjects with or without hypertension. Diabetes 1993;42: 764-772.
22. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
23. Hawk PD. Kjeldhal method. In Practical Physiological Chemistry. Toronto: Blackiston, 1947: 814-822.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419.
25. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23: 57-63.
26. Snedecor GW, Cochran WG. Statistical Methods. Ames, IA: Iowa State University Press, 1967.
27. Makimattila S, Virkamaki A, Groop PH, Cockcroft J, Utriainen T, Fagerudd J et al. Chronic hyperglycaemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996;94: 1276-1282.
28. Lewis TV, Dart AM, Chin-Dusting JP. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol 1999;33: 805-812.
29. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med 1990;323: 22-27.
30. Pinkney JH, Stehouver CDA, Coppack SW, Yudkin JS. Endothelial dysfunction: Cause of the Insulin Resistance Syndrome. Diabetes 1997;46: S9-S13.
31. Bonadonna RC, Bonora E. Glucose and free fatty acid metabolism in human obesity. Relationship with insulin resistance. Diabetes Rev 1997;5: 21-51.
32. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-α: A key component of the obesity-diabetes link. Diabetes 1994;43: 1271-1278.
33. Steppan CM, Bailey ST, Bhat SID, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001;409: 307-312.
34. Bjorntorp P. Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev 1999;15: 427-441.
35. Bjorntorp P. Androgens, the metabolic syndrome, and non-insulin-dependent diabetes mellitus. Ann NY Acad Sci 1993;676: 242-252.
36. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E et al. Insulin resistance and insulin secretory disfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993;329: 1988-1995.
37. Laakso M. How good a marker is insulin level for insulin resistance. Am J Epidemiol 1993;137: 959-965.
38. Haffner SM, Valdez RA, Hazuda HH, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992;41: 715-722.
39. Maheux P, Azhar S, Kern PA, Chen YD, Reaven GM. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 1997;40: 850-858.
40. Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 1996;19: 390-393.
41. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol 1999;84: 28-32.
42. Quinones-Galvan A, Ferrannini E. Renal effects of insulin in man. J Nephrol 1997;10: 188-191.
43. Sowers JR. At the cutting edge. Insulin resistance and hypertension. Mol Cell Endocrinol 1990;74: C87-C89.
44. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic Whites, and Hispanics with NIDDM. The Insulin Resistance Atherosclerosis Study. Diabetes 1997;46: 63-69.
45. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 1998;47: 1643-1649.
46. Lillioja SID, Mott DM, Zawadki JK, Young AA, Abbott WGH, Knowler WCet al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987;36: 1329-1335.
47. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widèn E, Schalin C et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989;321: 337-343.
48. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 1998;101: 86-96.
49. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T et al. Homeostasis Model Assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulphonylureas. Diabetes Care 1999;22: 818-822.
50. Bressler R, Johnson DG. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997;157: 836-848.
51. Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 1997;102: 99-110.